Published works

Category

Chronic Kidney Disease (CKD)

  • 165 Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease. Can J Vet Res.2021
    PubMed
  • 164 Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients. J Med Biochem.2020
    doi: 10.2478/jomb-2019-0037. PubMed
  • 163 Liver-type fatty acid-binding protein and neutrophil gelatinase-associated lipocalin in cats with chronic kidney disease and hyperthyroidism. J Vet Intern Med.2021
    doi: 10.1111/jvim.16074. PubMed
  • 162 Predictive value of novel biomarkers for chronic kidney disease among workers occupationally exposed to silica. Toxicol Ind Health.2021
    doi: 10.1177/0748233721990304. PubMed

Show all data ▶

Acute Kidney Injury (AKI)

  • 159Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients. Am J Transplant. 2020PubMed
  • 156Urinary biomarkers of kidney tubule injury, risk of acute kidney injury, and mortality in patients with acute ischaemic stroke treated at a stroke care unit. Eur J Neurol. 2020PubMed
  • 155Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020PubMed

Show all data ▶

Toxicology

  • 153Early changes in tubular dysfunction markers and phosphorus metabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleoside analog therapy for chronic hepatitis B patients. Hepatol Res.2020PubMed
  • 145The influence of renal function by ibuprofen treatment for patent ductus arteriosus in extremely low-birth-weight infants. Pediatr Int. 2019PubMed
  • 140Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study.J Pharm Health Care Sci.2019PubMed

Show all data ▶

Pharmacology

  • 138Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.Diabetol Int.2018PubMed
  • 136Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.Naunyn Schmiedebergs Arch Pharmacol.2018PubMed
  • 129Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucoselowering-independent manner.BMJ Open Diabetes Res Care.2017PubMed

Show all data ▶

Exercise

  • 148 Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: a post-hoc analysis of a randomized controlled trial. Ther Apher Dial.2020PubMed
  • 139Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice.Hypertens Res.2019PubMed
  • 124Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.Clin Exp Hypertens.2017PubMed

Show all data ▶

Category

Download product leaflet

For nonclinical safety evaluation

Urinary L-FABP kits for Rat, Dog, Cat, Monkey and Pig are available for the purpose of monitoring drug nephrotoxicity and drug effectiveness.
Top ▲ Home ▶